FAM156B
gene geneOn this page
Summary
FAM156B (family with sequence similarity 156 member B, HGNC:31962) is a protein-coding gene on chromosome Xp11.22, encoding Protein FAM156A/FAM156B (Q8NDB6).
Predicted to enable methylated histone binding activity. Located in nuclear envelope.
Source: NCBI Gene 727866 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 1 total
- MANE Select transcript:
NM_001321178
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:31962 |
| Approved symbol | FAM156B |
| Name | family with sequence similarity 156 member B |
| Location | Xp11.22 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000179304 |
| Ensembl biotype | protein_coding |
| Entrez | 727866 |
Gene structure
Transcript identifiers
Ensembl transcripts: 23 — 23 protein_coding
ENST00000416841, ENST00000509613, ENST00000593751, ENST00000610405, ENST00000610609, ENST00000612188, ENST00000616419, ENST00000619346, ENST00000872798, ENST00000872799, ENST00000872800, ENST00000872801, ENST00000872802, ENST00000872803, ENST00000872804, ENST00000946100, ENST00000946101, ENST00000946102, ENST00000946103, ENST00000946104, ENST00000946105, ENST00000946106, ENST00000946107
RefSeq mRNA: 10 — MANE Select: NM_001321178
NM_001099684, NM_001321178, NM_001321179, NM_001321180, NM_001321181, NM_001321182, NM_001321183, NM_001321186, NM_001321187, NM_001321188
CCDS: CCDS43957
Canonical transcript exons
ENST00000416841 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002207946 | 52907109 | 52908560 |
| ENSE00002270563 | 52897330 | 52899541 |
| ENSE00003734130 | 52900568 | 52900660 |
Expression profiles
Bgee: expression breadth ubiquitous, 133 present calls, max score 95.48.
FANTOM5 (CAGE): breadth broad, TPM avg 0.5680 / max 18.3341, expressed in 304 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 209706 | 0.5680 | 304 |
| 209705 | 0.0091 | 5 |
Top tissues by expression
133 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| pituitary gland | UBERON:0000007 | 95.48 | gold quality |
| adenohypophysis | UBERON:0002196 | 94.62 | gold quality |
| right uterine tube | UBERON:0001302 | 94.39 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 93.75 | gold quality |
| placenta | UBERON:0001987 | 93.67 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 93.34 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 93.04 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 92.97 | gold quality |
| cerebellar cortex | UBERON:0002129 | 92.79 | gold quality |
| cerebellum | UBERON:0002037 | 92.70 | gold quality |
| hypothalamus | UBERON:0001898 | 92.15 | gold quality |
| right adrenal gland | UBERON:0001233 | 92.05 | gold quality |
| right frontal lobe | UBERON:0002810 | 91.75 | gold quality |
| skin of abdomen | UBERON:0001416 | 91.61 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 91.55 | gold quality |
| left adrenal gland | UBERON:0001234 | 91.44 | gold quality |
| skin of leg | UBERON:0001511 | 91.37 | gold quality |
| spleen | UBERON:0002106 | 91.24 | gold quality |
| zone of skin | UBERON:0000014 | 91.23 | gold quality |
| tibial nerve | UBERON:0001323 | 91.23 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 91.19 | gold quality |
| subcutaneous adipose tissue | UBERON:0002190 | 91.09 | gold quality |
| putamen | UBERON:0001874 | 90.72 | gold quality |
| adipose tissue | UBERON:0001013 | 90.45 | gold quality |
| left uterine tube | UBERON:0001303 | 90.43 | gold quality |
| nucleus accumbens | UBERON:0001882 | 90.30 | gold quality |
| amygdala | UBERON:0001876 | 90.14 | gold quality |
| caudate nucleus | UBERON:0001873 | 90.12 | gold quality |
| brain | UBERON:0000955 | 90.11 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 90.09 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-6701 | yes | 45.28 |
| E-ANND-3 | yes | 3.42 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
18 targeting FAM156B, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-5002-5P | 99.76 | 70.84 | 1763 |
| HSA-MIR-5004-5P | 99.68 | 66.63 | 1294 |
| HSA-MIR-3202 | 99.66 | 67.70 | 2737 |
| HSA-MIR-3685 | 99.62 | 68.83 | 1621 |
| HSA-MIR-7152-5P | 99.60 | 69.33 | 2094 |
| HSA-MIR-888-3P | 99.53 | 69.77 | 1057 |
| HSA-MIR-4672 | 99.50 | 71.58 | 2893 |
| HSA-MIR-7515 | 99.31 | 68.22 | 1795 |
| HSA-MIR-155-3P | 99.03 | 67.99 | 924 |
| HSA-MIR-3619-5P | 99.00 | 68.87 | 2308 |
| HSA-MIR-4751 | 98.80 | 64.95 | 525 |
| HSA-MIR-214-3P | 98.71 | 68.12 | 2128 |
| HSA-MIR-761 | 98.71 | 68.07 | 2051 |
| HSA-MIR-9500 | 98.62 | 66.54 | 1845 |
| HSA-MIR-7112-3P | 97.67 | 68.77 | 948 |
| HSA-MIR-3928-3P | 97.61 | 66.53 | 1096 |
| HSA-MIR-5681B | 94.82 | 69.30 | 514 |
| HSA-MIR-2277-3P | 91.94 | 62.27 | 299 |
Literature-anchored findings (GeneRIF, showing 1)
- Methylation of three genes encoded by X chromosome in blood leukocytes and colorectal cancer risk. (PMID:34145793)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Vcf2 | ENSMUSG00000041353 |
| rattus_norvegicus | Vcf2 | ENSRNOG00000090943 |
Paralogs (1): FAM156A (ENSG00000268350)
Protein
Protein identifiers
Protein FAM156A/FAM156B — Q8NDB6 (reviewed: Q8NDB6)
Alternative names: Transmembrane protein 29/29B
All UniProt accessions (4): A0A087WZE8, A0A087WZZ1, A0A087X2H2, Q8NDB6
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Membrane.
RefSeq proteins (10): NP_001093154, NP_001308107, NP_001308108, NP_001308109, NP_001308110, NP_001308111, NP_001308112, NP_001308115, NP_001308116, NP_001308117 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR029096 | Dppa3 | Family |
Pfam: PF15549
UniProt features (13 total): sequence conflict 5, region of interest 2, compositionally biased region 2, modified residue 2, chain 1, transmembrane region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8NDB6-F1 | 68.68 | 0.18 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (2): 1, 114
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 7 (showing top):
GOCC_NUCLEAR_ENVELOPE, GOCC_ORGANELLE_ENVELOPE, chrXp11, MIR5002_5P, MIR155_3P, MIR5681B, THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN
GO Biological Process (0):
GO Molecular Function (2): protein binding (GO:0005515), obsolete methylated histone binding (GO:0035064)
GO Cellular Component (2): nuclear envelope (GO:0005635), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
| nucleus | 1 |
| endomembrane system | 1 |
| organelle envelope | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
174 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| FAM156B | RBM41 | Q96IZ5 | 456 |
| FAM156B | TMEM164 | Q5U3C3 | 444 |
| FAM156B | DYDC2 | Q96IM9 | 380 |
| FAM156B | NME6 | O75414 | 370 |
| FAM156B | PPP1R3F | Q6ZSY5 | 369 |
| FAM156B | GOLGA8B | A8MQT2 | 358 |
| FAM156B | GNB4 | Q9HAV0 | 348 |
| FAM156B | MRPS25 | P82663 | 348 |
| FAM156B | DEF8 | Q6ZN54 | 348 |
| FAM156B | GALNT16 | Q8N428 | 348 |
| FAM156B | RBM33 | Q96EV2 | 348 |
| FAM156B | CCDC14 | Q49A88 | 348 |
| FAM156B | TMEM106A | Q96A25 | 348 |
| FAM156B | DNAAF6 | Q9NQM4 | 336 |
| FAM156B | GAB3 | Q8WWW8 | 328 |
IntAct
21 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| SAT1 | FAM156B | psi-mi:“MI:0915”(physical association) | 0.560 |
| TEX11 | FAM156B | psi-mi:“MI:0915”(physical association) | 0.560 |
| ATRIP | FAM156B | psi-mi:“MI:0915”(physical association) | 0.560 |
| FAM156B | TFIP11 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FAM156B | SAT1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FAM156B | TEX11 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TFIP11 | FAM156B | psi-mi:“MI:0915”(physical association) | 0.560 |
| FAM156B | CRACR2A | psi-mi:“MI:0915”(physical association) | 0.560 |
| GADD45G | FAM156B | psi-mi:“MI:0915”(physical association) | 0.560 |
| FAM156B | PB2 | psi-mi:“MI:0915”(physical association) | 0.370 |
| MAGEA11 | FAM156B | psi-mi:“MI:0915”(physical association) | 0.370 |
| CRACR2A | FAM156B | psi-mi:“MI:0915”(physical association) | 0.000 |
| GADD45G | FAM156B | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (10): FAM156A (Two-hybrid), FAM156A (Two-hybrid), TEX11 (Two-hybrid), ATRIP (Two-hybrid), FAM156A (Two-hybrid), FAM156B (Two-hybrid), FAM156A (Two-hybrid), FAM156B (Two-hybrid), FAM156A (Two-hybrid), FAM156A (Affinity Capture-RNA)
ESM2 similar proteins: A0A1B0GVQ3, A0A1W2PPK0, A0A1W2PPM1, A2A9I7, A6NCI8, A6QQS3, A7XCE8, E9PI22, E9PXT9, O15016, O91083, P09414, P0DMB1, P17923, P18804, P20879, P35965, P49750, Q0P670, Q12857, Q1RMX6, Q32LN6, Q32MG2, Q3B8N5, Q3T016, Q3V0A6, Q4JK59, Q5BI31, Q5T035, Q5ZKH6, Q642A3, Q6AXV6, Q6IMN6, Q6P1W5, Q6PEX7, Q6X4T0, Q80YD3, Q86UF4, Q8BII1, Q8C5V0
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
1 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 1 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
821 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| X:52897406:GCGC:G | donor_gain | 1.0000 |
| X:52897451:G:GT | donor_gain | 1.0000 |
| X:52897453:A:T | donor_gain | 1.0000 |
| X:52897408:GC:G | donor_gain | 0.9900 |
| X:52897410:G:GG | donor_gain | 0.9900 |
| X:52897433:A:T | donor_gain | 0.9900 |
| X:52897458:C:CG | donor_gain | 0.9900 |
| X:52907095:A:AG | acceptor_gain | 0.9900 |
| X:52907095:ACCTT:A | acceptor_gain | 0.9900 |
| X:52907096:C:G | acceptor_gain | 0.9900 |
| X:52907101:C:CA | acceptor_gain | 0.9900 |
| X:52907107:A:AG | acceptor_gain | 0.9900 |
| X:52907107:AGTCT:A | acceptor_gain | 0.9900 |
| X:52907108:G:GA | acceptor_gain | 0.9900 |
| X:52907108:GT:G | acceptor_gain | 0.9900 |
| X:52907108:GTC:G | acceptor_gain | 0.9900 |
| X:52907108:GTCT:G | acceptor_gain | 0.9900 |
| X:52907108:GTCTG:G | acceptor_gain | 0.9900 |
| X:52897428:G:GT | donor_gain | 0.9800 |
| X:52897431:G:GT | donor_gain | 0.9800 |
| X:52897437:C:T | donor_gain | 0.9800 |
| X:52897452:G:GT | donor_gain | 0.9800 |
| X:52897461:A:T | donor_gain | 0.9800 |
| X:52897540:G:GT | donor_gain | 0.9800 |
| X:52903442:TGTA:T | donor_gain | 0.9800 |
| X:52907092:A:AG | acceptor_gain | 0.9800 |
| X:52907093:T:G | acceptor_gain | 0.9800 |
| X:52907099:T:TA | acceptor_gain | 0.9800 |
| X:52907103:TTGCA:T | acceptor_loss | 0.9800 |
| X:52907104:T:A | acceptor_gain | 0.9800 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS111420157 (X:52904891 C>T), RS112522760 (X:52893104 G>A), RS113224458 (X:52893628 C>A), RS1159018974 (X:52893320 A>C), RS1159076535 (X:52904629 C>T), RS1162050936 (X:52904171 GTTGTATTGTA>G,GTTGTA,GTTGTATTGTATTGTA), RS1162546474 (X:52904459 C>T), RS1163573170 (X:52893117 A>C), RS1165168452 (X:52904023 T>A,C), RS1167833482 (X:52904331 G>A), RS1167915145 (X:52893093 T>C,G), RS1171474341 (X:52904012 AGTTGGGGT>A), RS1171537449 (X:52903912 G>T), RS1172255458 (X:52904254 G>A), RS1173380565 (X:52892855 G>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
11 total (human), top 11 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| butyraldehyde | decreases expression | 1 |
| methacrylaldehyde | increases expression, affects cotreatment | 1 |
| Leflunomide | decreases expression | 1 |
| Acrolein | increases expression, affects cotreatment | 1 |
| Cadmium | increases expression, increases abundance | 1 |
| Ozone | affects cotreatment, increases expression | 1 |
| Smoke | decreases expression | 1 |
| Urethane | decreases expression | 1 |
| Cyclosporine | increases methylation | 1 |
| Cadmium Chloride | increases abundance, increases expression | 1 |
| S-Nitrosoglutathione | affects expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.